ALGN vs ELVN · P/E 35, rev $2.10B vs $2.11B cap
Align Technology Inc (ALGN) versus Enliven Therapeutics Inc. (ELVN) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Enliven Therapeutics Inc. (ELVN) is a biotechnology company listed on US.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
ELVN does not have a complete income-statement cache yet.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. ELVN currently screens at market cap $2.11B.
Not investment advice. Open the ALGN and ELVN stock pages for the full models.
Not investment advice.